← Open Payments lookup

REBECCA RWUBUSISI: Open Payments

NPI 1700423597 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,773 in 78 payments from 7 companies in 2025. Trend: 2023 $1,231 · 2024 $1,797 · 2025 $1,773

Food & beverage: $1,736Education: $37
CompanyPaymentsAmount
Gilead Sciences, Inc.28$746
ViiV Healthcare Company19$418
ABBVIE INC.18$275
Merck Sharp & Dohme LLC8$236
Astellas Pharma US Inc2$42
Aimmune Therapeutics, Inc.2$34
Invivyd Inc1$22

Products named: DOVATO, DALVANCE, ZERBAXA, APRETUDE, EMBLAVEO, Biktarvy, CABENUVA, Cresemba.

Industry payments across CO — which companies pay providers there.